Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.

Biotechnology

Health Care

Life Sciences

Haemalogix

Haemalogix's headquarters in Sydney, Australia

Bryce Carmine

David Gottlieb

John Cullity

Alan Liddle

Paul Richardson

Geoffrey Nichol

Andrew Spencer

Simon Harrison

Jesus San-Miguel

The Advisory Team at Haemalogix plays a crucial role in guiding the company's strategic direction in immuno-oncology and immune-therapies. Comprising experienced advisors, including a Chief Medical Advisor, the team provides expert insights on clinical development, regulatory strategies, and market trends to enhance product offerings and ensure alignment with scientific and commercial goals. Their collective expertise supports innovation and helps navigate the complexities of bringing novel therapies to market.

Advisory Team

The Leadership Team at Haemalogix is responsible for setting the strategic direction of the company, driving innovation in immuno-oncology and immune-therapies, and overseeing operations across research, development, and manufacturing. This team collaborates to ensure alignment between scientific advancements and business objectives, fostering growth and positioning Haemalogix as a leader in the field.

Haemalogix

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Haemalogix

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies